🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

Onconetix Inc (ONCO)

NASDAQ
Currency in USD
0.7101
+0.0783(+12.66%)
Closed
Pre Market
0.6900-0.0201(-2.83%)
ONCO Scorecard
Full Analysis
Operates with a significant debt burden
Fair Value
Day's Range
0.61130.7200
52 wk Range
0.590721.4000
Key Statistics
Edit
Prev. Close
0.7101
Open
0.6665
Day's Range
0.6113-0.72
52 wk Range
0.5907-21.4
Volume
145.59K
Average Vol. (3m)
732.66K
1-Year Change
-92.9%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ONCO Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory
Show more

Onconetix Inc Company Profile

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men’s health and oncology. It offers Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia; and Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.

Employees
12

Compare ONCO to Peers and Sector

Metrics to compare
ONCO
Peers
Sector
Relationship
P/E Ratio
−0.1x−1.4x−0.6x
PEG Ratio
0.00−0.010.00
Price / Book
−0.2x0.9x2.6x
Price / LTM Sales
4.0x13.3x3.2x
Upside (Analyst Target)
-338.6%46.2%
Fair Value Upside
Unlock18.0%7.0%Unlock

People Also Watch

0.500
FOXO
-1.96%
7.5300
RNAZ
-2.59%
3.370
PRFX
+0.60%
2.070
VS
+20.35%
7.4700
QUBT
-5.80%

FAQ

What Is the Onconetix (ONCO) Stock Price Today?

The Onconetix stock price today is 0.7101

What Stock Exchange Does Onconetix Trade On?

Onconetix is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Onconetix?

The stock symbol for Onconetix is "ONCO."

What Is the Onconetix Market Cap?

As of today, Onconetix market cap is 5.24M.

What is Onconetix Earnings Per Share?

The Onconetix EPS is -104.97.

From a Technical Analysis Perspective, Is ONCO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.